Literature DB >> 23066418

Changes in plasma IL4, TNFá and CRP in response to regular passive smoking at home among healthy school children in Khartoum, Sudan.

T H Merghani1, A Saeed, A Alawad.   

Abstract

BACKGROUND: Regular exposure to tobacco smoke at home causes airway inflammation and altered cytokine regulation; however, there is variation between individuals of different countries.
OBJECTIVE: To determine effects of passive smoking on plasma IL4, TNFá, and CRP in healthy male school-children in Khartoum.
METHODS: A total of 135 male school-pupils (69 passive smokers and 66 non-smokers) were selected randomly from three primary schools for boys in Khartoum. Information about smoking history was collected from each pupil and his parents using a questionnaire. Plasma CRP, IL4 and TNFá were measured using commercially available ELISA kits.
RESULTS: Plasma IL4 and TNFá in the passive smokers (mean ± SEM) is at 2.92 ± 0.93 and 19.78 ± 4.67 pg/ml respectively; whereas in the non-smokers . It is at 0.45 ± 0.28 and 5.05 ± 1.54 pg/ml respectively. The difference between the two groups is statistically significant (p <0.05). The mean plasma IL4 and TNFá were lowest with no exposure, higher with moderate exposure, and highest with heavy exposure (P < 0.05). Plasma CRP showed insignificant difference between the two groups.
CONCLUSION: Passive smoking causes significant rise in plasma TNFá and IL4 with a dose dependent effect among school-pupils in Khartoum.

Entities:  

Keywords:  CRP; IL4; TNFa; children; passive smoking

Mesh:

Substances:

Year:  2012        PMID: 23066418      PMCID: PMC3462520     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  38 in total

1.  Raised C-reactive protein levels in serum from smokers.

Authors:  I Das
Journal:  Clin Chim Acta       Date:  1985-11-29       Impact factor: 3.786

2.  Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men.

Authors:  J Helmersson; A Larsson; B Vessby; S Basu
Journal:  Atherosclerosis       Date:  2005-04-26       Impact factor: 5.162

3.  [Lung injury caused by passive smoking and its effects on cytokines in rats].

Authors:  B Pang; C Wang; X Weng; X Tang; H Zhang; S Niu; Y Mao; P Xin; X Huang; H Zhang
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2000-03

Review 4.  The changing cigarette.

Authors:  D Hoffmann; M V Djordjevic; I Hoffmann
Journal:  Prev Med       Date:  1997 Jul-Aug       Impact factor: 4.018

Review 5.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

6.  Involvement of nitric oxide in acute lung inflammation induced by cigarette smoke in the mouse.

Authors:  Samuel Santos Valença; Wagner Alves Pimenta; Carlos Romualdo Rueff-Barroso; Thiago Santos Ferreira; Angela Castro Resende; Roberto Soares de Moura; Luís Cristóvão Porto
Journal:  Nitric Oxide       Date:  2008-12-06       Impact factor: 4.427

7.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

Authors:  P M Ridker; R J Glynn; C H Hennekens
Journal:  Circulation       Date:  1998-05-26       Impact factor: 29.690

8.  Acute and short-term effects of secondhand smoke on lung function and cytokine production.

Authors:  Andreas D Flouris; Giorgos S Metsios; Andres E Carrillo; Athanasios Z Jamurtas; Konstantinos Gourgoulianis; Theodoros Kiropoulos; Manolis N Tzatzarakis; Aristidis M Tsatsakis; Yiannis Koutedakis
Journal:  Am J Respir Crit Care Med       Date:  2009-03-05       Impact factor: 21.405

9.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.

Authors:  V M Keatings; P D Collins; D M Scott; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

10.  Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese subjects.

Authors:  Katarzyna Popko; E Gorska; A Stelmaszczyk-Emmel; R Plywaczewski; A Stoklosa; D Gorecka; B Pyrzak; U Demkow
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

View more
  6 in total

1.  Back to our roots: infections, HIV and maternal mortality in Africa.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

2.  Effects of passive smoking on students at College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh.

Authors:  Abdullah Alanazi; Farhan Al Enezi; Mohammd Mesfer Alqahtani; Turki Faleh Alshammari; Mumtaz Ahmed Ansari; Saleh Al-Oraibi; Shoeb Qureshi
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

3.  Secondhand Smoke Exposure and Subclinical Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Miranda R Jones; Hoda S Magid; Mahmoud Al-Rifai; John W McEvoy; Joel D Kaufman; Karen D Hinckley Stukovsky; Moyses Szklo; Joseph Polak; Gregory L Burke; Wendy S Post; Michael J Blaha; Ana Navas-Acien
Journal:  J Am Heart Assoc       Date:  2016-12-19       Impact factor: 5.501

Review 4.  Plausible Roles for RAGE in Conditions Exacerbated by Direct and Indirect (Secondhand) Smoke Exposure.

Authors:  Joshua B Lewis; Kelsey M Hirschi; Juan A Arroyo; Benjamin T Bikman; David L Kooyman; Paul R Reynolds
Journal:  Int J Mol Sci       Date:  2017-03-17       Impact factor: 5.923

5.  NF-κB-modulated miR-130a targets TNF-α in cervical cancer cells.

Authors:  Jian Zhang; Haidong Wu; Pu Li; Yanzheng Zhao; Min Liu; Hua Tang
Journal:  J Transl Med       Date:  2014-06-01       Impact factor: 5.531

6.  The Association between the Occurrence of Asthma and Antecedents of Exposure to Environmental Tobacco Smoke in the Previous Year in Children: An Incidence-Density Study.

Authors:  Hayat Bentouhami; Lidia Casas; Joost Weyler
Journal:  Int J Environ Res Public Health       Date:  2022-03-02       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.